ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 21304530

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.

Yoshino H and 8 others. Br J Cancer, 2011. Cited by 247 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Papers, record 21304530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21304530

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
247
iCite
Relative citation ratio, by iCite
6.54
iCite
Revised in PubMed
2025-02-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yoshino HH
2Chiyomaru TT
3Enokida HH
4Kawakami KK
5Tatarano SS
6Nishiyama KK
7Nohata NN
8Seki NN
9Nakagawa MM

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Microfilament ProteinsMajor topic
Muscle ProteinsMajor topic
Urinary Bladder NeoplasmsMajor topic
Apoptosis
Cell Line, Tumor
Cell Movement
Cell Proliferation
Down-Regulation
Humans
Transfection

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119,848,416Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma.J Proteome Res2009https://conductscience.org/library/papers/19848416PubMed
219,378,336Identification of novel microRNA targets based on microRNA signatures in bladder cancer.Int J Cancer2009https://conductscience.org/library/papers/19378336PubMed
319,843,336Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.BMC Cancer2009https://conductscience.org/library/papers/19843336PubMed
418,197,166Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nat Rev Genet2008https://conductscience.org/library/papers/18197166PubMed
515,756,260Identification and analysis of tumour-associated antigens in hepatocellular carcinoma.Br J Cancer2005https://conductscience.org/library/papers/15756260PubMed
619,506,341MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2.Int Heart J2009https://conductscience.org/library/papers/19506341PubMed
716,380,711The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.Nat Genet2006https://conductscience.org/library/papers/16380711PubMed
820,369,013Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.PLoS Comput Biol2010https://conductscience.org/library/papers/20369013PubMed
918,818,206Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.J Biol Chem2008https://conductscience.org/library/papers/18818206PubMed
1019,930,159Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis.Cancer Sci2010https://conductscience.org/library/papers/19930159PubMed

1 to 10 of 37

See all 37 references

Cited by153

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 247 citations.

PMIDTitleJournalYearIn PapersSource
41,997,877miR-133a-3p and miR-338-3p shape neural crest derivatives in zebrafish.Life Sci Alliance2026https://conductscience.org/library/papers/41997877PubMed
41,934,428Evaluation of miRNA-133a-3p and miRNA-124-3p expression in atherosclerosis using real-time PCR and immunohistochemical methods.Indian J Med Res2026https://conductscience.org/library/papers/41934428PubMed
41,169,389CXCR7-TAGLN2 protein complex regulates invasion and metastasis in papillary thyroid carcinoma: a potential therapeutic target.Front Immunol2025https://conductscience.org/library/papers/41169389PubMed
40,932,257Co-expression of bovine leukemia virus and bovine foamy virus-derived miRNAs in naturally infected cattle.Microbiol Spectr2025https://conductscience.org/library/papers/40932257PubMed
40,799,501Purine Nucleoside Phosphorylase (PNP) as a Biomarker and Therapeutic Target in Muscle-Invasive Bladder Cancer.Clin Med Insights Oncol2025https://conductscience.org/library/papers/40799501PubMed
40,247,723TAGLN2-mediated Actin Cytoskeleton Stabilization Promotes Proliferation and Metastasis of Ovarian Carcinoma.Appl Immunohistochem Mol Morphol2025https://conductscience.org/library/papers/40247723PubMed
39,981,244Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.Front Immunol2025https://conductscience.org/library/papers/39981244PubMed
38,892,143LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/38892143PubMed
38,693,824miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.Technol Cancer Res Treat2024https://conductscience.org/library/papers/38693824PubMed
38,509,504Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer.BMC Cancer2024https://conductscience.org/library/papers/38509504PubMed

1 to 10 of 153

See all 153 cited by

Genes32

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
ARF4378PubTator's text mininghttps://conductscience.org/library/genes/378NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
C1QTNF5114,902PubTator's text mininghttps://conductscience.org/library/genes/114902NCBI Gene
CETN11,068PubTator's text mininghttps://conductscience.org/library/genes/1068NCBI Gene
FSCN16,624PubTator's text mininghttps://conductscience.org/library/genes/6624NCBI Gene
FSD179,187PubTator's text mininghttps://conductscience.org/library/genes/79187NCBI Gene
GAPDH2,597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GJA12,697PubTator's text mininghttps://conductscience.org/library/genes/2697NCBI Gene
GSTP12,950PubTator's text mininghttps://conductscience.org/library/genes/2950NCBI Gene

1 to 10 of 32

See all 32 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21304530

GET https://conductscience.org/api/papers/v1/21304530/references?page=2

API referenceFor AI assistants